Advances in Nursing & Midwifery

Vol. 33 No. 1 (2024)

Frequency of SARS-CoV-2 Infection after Vaccination in Health Care Workers in Ardabil, 2021

Advances in Nursing & Midwifery, Vol. 33 No. 1 (2024), 15 Dey 2024 , Page 16-21
https://doi.org/10.22037/anm.v33i1.43945

Abstract

Abstract
Introduction: The effectiveness and safety of COVID-19 vaccines have been reported, but there is limited information on their real-world effectiveness and reports of breakthrough infections. This study aimed to determine the frequency of COVID-19 infections after vaccination among medical interns and personnel in Ardabil city in 2021.
Methods: This cross-sectional descriptive study included 330 medical interns and personnel from Ardabil city hospitals. Participants were required to provide consent, have received at least one dose of the COVID-19 vaccine, and not have hearing or speech problems. Data was collected using a researcher-made questionnaire and analyzed using SPSS software.
Results: Most of the individuals involved (59.7%) were aged between 20 and 30, and 58.5% were women. The majority of the participants were married (60.6%), while physicians and nurses were the most frequently observed professional groups (with 39.7% and 29.1% respectively). Sinopharm and AstraZeneca vaccines were the most commonly used (39.4% and 17.9%, respectively). The majority of participants (67.3%) received three doses of the vaccine, and 27.1% of participants (92 people) reported getting sick at least 2 months after receiving the COVID-19 vaccine. There was no significant association between demographic variables and post-vaccine infection.
Conclusions: Although a substantial number of participants were infected with COVID-19 following vaccination, the severity of the illness was mostly mild, demonstrating the value of vaccination in lessening the impact of COVID-19.

Keywords:
  • Treatment Staff
  • COVID-19
  • Vaccination

How to Cite

Bahari, Y., Abootalebidariasari, G., Aghabalaii, M., & Mohammadzadeh Shahla, M. (2024). Frequency of SARS-CoV-2 Infection after Vaccination in Health Care Workers in Ardabil, 2021. Advances in Nursing & Midwifery, 33(1), 16–21. https://doi.org/10.22037/anm.v33i1.43945

References

Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls. Treasure Island (FL) StatPearls Publishing LLC.; 2025. www.ncbi.nlm.nih.gov/pubmed/32150360

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. doi: 10.1016/S0140-6736(20)30211-7 pmid: 32007143

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. doi: 10.1056/NEJMoa2002032 pmid: 32109013

Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020;382(21):2012-22. doi: 10.1056/NEJMoa2004500 pmid: 32227758

Della Polla G, Miraglia Del Giudice G, Pelullo CP, Angelillo IF. Bivalent second booster dose of the COVID-19 vaccine: Eligible populations' reasons for receiving in Italy. Hum Vaccin Immunother. 2023;19(1):2188856. doi: 10.1080/21645515.2023.2188856 pmid: 36988622

da Silva P. Vaccination against COVID-19 in health care workers. Rev Bras Med Trab. 2021;19(1):1-2. doi: 10.47626/1679-4435-2021-191 pmid: 33986774

Ng XL, Betzler BK, Ng S, Chee SP, Rajamani L, Singhal A, et al. The Eye of the Storm: COVID-19 Vaccination and the Eye. Ophthalmol Ther. 2022;11(1):81-100. doi: 10.1007/s40123-021-00415-5 pmid: 34914035

Dodd RH, Pickles K, Nickel B, Cvejic E, Ayre J, Batcup C, et al. Concerns and motivations about COVID-19 vaccination. Lancet Infect Dis. 2021;21(2):161-3. doi: 10.1016/S1473-3099(20)30926-9 pmid: 33338440

Sabnis R, Patil A, Shete N, Rastogi AK. Break-through COVID-19 infection rate with Indian strain in single-center healthcare Workers–A real world data. MedRxiv. 2021:201-7. doi: 10.1101/2021.07.02.21258881

Keehner J, Horton LE, Pfeffer MA, Longhurst CA, Schooley RT, Currier JS, et al. SARS-CoV-2 Infection after Vaccination in Health Care Workers in California. N Engl J Med. 2021;384(18):1774-5. doi: 10.1056/NEJMc2101927 pmid: 33755376

Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1 pmid: 33306989

Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397(10277):881-91. doi: 10.1016/S0140-6736(21)00432-3 pmid: 33617777

Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467-78. doi: 10.1016/S0140-6736(20)31604-4 pmid: 32702298

Atkins JL, Masoli JAH, Delgado J, Pilling LC, Kuo CL, Kuchel GA, et al. Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort. J Gerontol A Biol Sci Med Sci. 2020;75(11):2224-30. doi: 10.1093/gerona/glaa183 pmid: 32687551

Nandy K, Salunke A, Pathak SK, Pandey A, Doctor C, Puj K, et al. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Diabetes Metab Syndr. 2020;14(5):1017-25. doi: 10.1016/j.dsx.2020.06.064 pmid: 32634716

Garg A, Posa MK, Kumar A. Diabetes and deaths of COVID-19 patients: Systematic review of meta-analyses. Health Sci Rev (Oxf). 2023;7:100099. doi: 10.1016/j.hsr.2023.100099 pmid: 37229298

Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773. doi: 10.1016/S1473-3099(20)30195-X pmid: 32171390

Meo SA, Al-Khlaiwi T, Usmani AM, Meo AS, Klonoff DC, Hoang TD. Biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus COVID-19. J King Saud Univ Sci. 2020;32(4):2495-9. doi: 10.1016/j.jksus.2020.04.004 pmid: 32292261

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi: 10.1016/S0140-6736(20)30566-3 pmid: 32171076

Zou X, Li S, Fang M, Hu M, Bian Y, Ling J, et al. Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019. Crit Care Med. 2020;48(8):e657-e65. doi: 10.1097/CCM.0000000000004411 pmid: 32697506

  • Abstract Viewed: 166 times
  • pdf Downloaded: 126 times

Download Statastics

Information

Language